Retinal Markers in Neuroinflammatory Diseases: a Prospective Observational Study
Status: Recruiting
Location: See location...
Intervention Type: Other, Diagnostic test
Study Type: Observational
SUMMARY
The goal of this observational study, including patients with Multiple Sclerosis, patients with other neuroinflammatory diseases and healthy controls, is to determine the predictive value of retinal markers in predicting disease progression. Participants complete a questionnaire and undergo various non-invasive retinal routine clinical examinations.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• All groups:
⁃ Age \>18 years old
• Patients with Multiple Sclerosis:
⁃ Diagnosis of Multiple Sclerosis, according to the last revisions of the McDonald Criteria (2017)
• Patients with other neuroinflammatory diseases:
⁃ Diagnosis of Neuromyelitis optica spectrum disorder or Myelin oligodendrocyte glycoprotein antibody disease or other neuroinflammatory disorders other than Multiple Sclerosis
Locations
Other Locations
Switzerland
University Hospital Basel, Department of Neurology
RECRUITING
Basel
Contact Information
Primary
Athina Papadopoulou, PD Dr. med.
Athina.Papadopoulou@usb.ch
+41 61 32 85704
Time Frame
Start Date: 2024-01-31
Estimated Completion Date: 2029-02
Participants
Target number of participants: 500
Treatments
Healthy Controls
Healthy control subjects without neurological diseases
Patients with Multiple Sclerosis
Patients with other neuroinflammatory diseases of the CNS
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Basel, Switzerland
Collaborators: University of Basel